Annual total expenses:
$27.47B+$5.91B(+27.42%)Summary
- As of today (September 13, 2025), NVO annual total expenses is $27.47 billion, with the most recent change of +$5.91 billion (+27.42%) on December 31, 2024.
- During the last 3 years, NVO annual total expenses has risen by +$12.68 billion (+85.76%).
- NVO annual total expenses is now at all-time high.
Performance
NVO Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$7.65B+$734.39M(+10.61%)Summary
- As of today (September 13, 2025), NVO quarterly total expenses is $7.65 billion, with the most recent change of +$734.39 million (+10.61%) on June 1, 2025.
- Over the past year, NVO quarterly total expenses has increased by +$726.36 million (+10.48%).
- NVO quarterly total expenses is now -6.83% below its all-time high of $8.22 billion, reached on December 31, 2024.
Performance
NVO Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
NVO Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +27.4% | +10.5% |
3 y3 years | +85.8% | +91.5% |
5 y5 years | +120.6% | +167.5% |
NVO Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +85.8% | -6.8% | +91.5% |
5 y | 5-year | at high | +120.6% | -6.8% | +167.5% |
alltime | all time | at high | >+9999.0% | -6.8% | +4146.7% |
NVO Total expenses History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $7.65B(+10.6%) |
Mar 2025 | - | $6.92B(-15.8%) |
Dec 2024 | $27.47B(+27.4%) | $8.22B(+26.8%) |
Sep 2024 | - | $6.48B(-6.5%) |
Jun 2024 | - | $6.93B(+19.2%) |
Mar 2024 | - | $5.81B(-8.2%) |
Dec 2023 | $21.56B(+25.7%) | $6.33B(+19.6%) |
Sep 2023 | - | $5.29B(+3.9%) |
Jun 2023 | - | $5.09B(+5.3%) |
Mar 2023 | - | $4.84B(+2.2%) |
Dec 2022 | $17.15B(+16.0%) | $4.73B(+12.2%) |
Sep 2022 | - | $4.22B(+5.5%) |
Jun 2022 | - | $4.00B(-4.7%) |
Mar 2022 | - | $4.19B(-0.5%) |
Dec 2021 | $14.79B(+14.0%) | $4.22B(+13.2%) |
Sep 2021 | - | $3.73B(+9.8%) |
Jun 2021 | - | $3.39B(-1.1%) |
Mar 2021 | - | $3.43B(-6.1%) |
Dec 2020 | $12.97B(+4.1%) | $3.66B(+12.9%) |
Sep 2020 | - | $3.24B(+13.2%) |
Jun 2020 | - | $2.86B(-11.7%) |
Mar 2020 | - | $3.24B(-7.7%) |
Dec 2019 | $12.45B(+7.5%) | $3.51B(+17.4%) |
Sep 2019 | - | $2.99B(-2.7%) |
Jun 2019 | - | $3.08B(+7.3%) |
Mar 2019 | - | $2.87B(-11.7%) |
Dec 2018 | $11.59B(+3.9%) | $3.25B(+11.2%) |
Sep 2018 | - | $2.92B(+7.1%) |
Jun 2018 | - | $2.73B(+2.2%) |
Mar 2018 | - | $2.67B(-14.5%) |
Dec 2017 | $11.16B(+1.7%) | $3.12B(+17.4%) |
Sep 2017 | - | $2.66B(-3.9%) |
Jun 2017 | - | $2.77B(+5.5%) |
Mar 2017 | - | $2.62B(-13.3%) |
Dec 2016 | $10.97B(+1.0%) | $3.02B(+13.7%) |
Sep 2016 | - | $2.66B(+0.2%) |
Jun 2016 | - | $2.65B(+1.2%) |
Mar 2016 | - | $2.62B(-13.2%) |
Dec 2015 | $10.86B(-2.0%) | $3.02B(+10.3%) |
Sep 2015 | - | $2.74B(-1.2%) |
Jun 2015 | - | $2.77B(+20.0%) |
Mar 2015 | - | $2.31B(-23.7%) |
Dec 2014 | $11.09B(+6.7%) | $3.03B(+8.2%) |
Sep 2014 | - | $2.80B(+4.1%) |
Jun 2014 | - | $2.69B(+5.5%) |
Mar 2014 | - | $2.55B(-10.7%) |
Dec 2013 | $10.39B(+6.4%) | $2.86B(+14.1%) |
Sep 2013 | - | $2.50B(-2.4%) |
Jun 2013 | - | $2.56B(+3.5%) |
Mar 2013 | - | $2.48B(-6.3%) |
Dec 2012 | $9.77B(+6.2%) | $2.64B(+11.1%) |
Sep 2012 | - | $2.38B(-2.2%) |
Jun 2012 | - | $2.43B(+5.5%) |
Mar 2012 | - | $2.31B(-5.1%) |
Dec 2011 | $9.19B(+11.6%) | $2.43B(+4.1%) |
Sep 2011 | - | $2.34B(+2.0%) |
Jun 2011 | - | $2.29B(+7.4%) |
Mar 2011 | - | $2.13B(-3.8%) |
Dec 2010 | $8.24B | $2.22B(+6.5%) |
Sep 2010 | - | $2.08B(+3.0%) |
Jun 2010 | - | $2.02B(+5.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $1.92B(-9.8%) |
Dec 2009 | $7.53B(+6.8%) | $2.13B(+13.7%) |
Sep 2009 | - | $1.87B(+2.4%) |
Jun 2009 | - | $1.83B(+6.9%) |
Mar 2009 | - | $1.71B(-5.5%) |
Dec 2008 | $7.05B(+15.2%) | $1.81B(+4.9%) |
Sep 2008 | - | $1.73B(-4.5%) |
Jun 2008 | - | $1.81B(+6.8%) |
Mar 2008 | - | $1.69B(-12.5%) |
Dec 2007 | $6.12B(+12.6%) | $1.94B(+26.0%) |
Sep 2007 | - | $1.54B(+22.8%) |
Jun 2007 | - | $1.25B(-12.3%) |
Mar 2007 | - | $1.43B(-5.9%) |
Dec 2006 | $5.43B(+16.9%) | $1.51B(+13.6%) |
Sep 2006 | - | $1.33B(-1.0%) |
Jun 2006 | - | $1.35B(+8.0%) |
Mar 2006 | - | $1.25B(-4.9%) |
Dec 2005 | $4.65B(+15.9%) | $1.31B(+13.9%) |
Sep 2005 | - | $1.15B(+3.3%) |
Jun 2005 | - | $1.11B(+5.0%) |
Mar 2005 | - | $1.06B(-6.1%) |
Dec 2004 | $4.01B(+21.6%) | $1.13B(+11.2%) |
Sep 2004 | - | $1.02B(+6.5%) |
Jun 2004 | - | $953.93M(+4.1%) |
Mar 2004 | - | $916.25M(-2.3%) |
Dec 2003 | $3.30B(+23.2%) | $937.53M(+11.0%) |
Sep 2003 | - | $844.46M(+5.4%) |
Jun 2003 | - | $800.99M(+10.6%) |
Mar 2003 | - | $724.35M(-2.9%) |
Dec 2002 | $2.68B(+12.0%) | $746.05M(+3.5%) |
Sep 2002 | - | $720.78M(+7.1%) |
Jun 2002 | - | $673.00M(+22.5%) |
Mar 2002 | - | $549.48M(-16.2%) |
Dec 2001 | $2.39B(+9.2%) | $655.97M(+9.4%) |
Sep 2001 | - | $599.52M(+0.2%) |
Jun 2001 | - | $598.17M(+11.8%) |
Mar 2001 | - | $534.85M(+196.7%) |
Dec 2000 | $2.19B(-17.4%) | $180.26M(-72.1%) |
Mar 2000 | - | $645.93M(-0.1%) |
Dec 1999 | $2.65B(+14.5%) | - |
Jun 1999 | - | $646.73M(+3.2%) |
Mar 1999 | - | $626.81M |
Dec 1998 | $2.31B(+3.8%) | - |
Dec 1997 | $2.23B(-1.2%) | - |
Dec 1996 | $2.26B(+3.9%) | - |
Dec 1995 | $2.17B(+14.1%) | - |
Dec 1994 | $1.90B(+12.9%) | - |
Dec 1993 | $1.68B(+6.8%) | - |
Dec 1992 | $1.58B(+18.6%) | - |
Dec 1991 | $1.33B(+11.7%) | - |
Dec 1990 | $1.19B(+30.8%) | - |
Dec 1989 | $910.86M(+32.6%) | - |
Dec 1988 | $687.14M(+5.9%) | - |
Dec 1987 | $648.56M(+42.2%) | - |
Dec 1986 | $456.09M(+37.4%) | - |
Dec 1985 | $331.95M(+11.5%) | - |
Dec 1984 | $297.65M(+1.9%) | - |
Dec 1983 | $292.14M(+14.5%) | - |
Dec 1982 | $255.09M(-3.9%) | - |
Dec 1981 | $265.42M(+6.6%) | - |
Dec 1980 | $249.07M | - |
FAQ
- What is Novo Nordisk A/S annual total expenses?
- What is the all time high annual total expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total expenses year-on-year change?
- What is Novo Nordisk A/S quarterly total expenses?
- What is the all time high quarterly total expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly total expenses year-on-year change?
What is Novo Nordisk A/S annual total expenses?
The current annual total expenses of NVO is $27.47B
What is the all time high annual total expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total expenses is $27.47B
What is Novo Nordisk A/S annual total expenses year-on-year change?
Over the past year, NVO annual total expenses has changed by +$5.91B (+27.42%)
What is Novo Nordisk A/S quarterly total expenses?
The current quarterly total expenses of NVO is $7.65B
What is the all time high quarterly total expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total expenses is $8.22B
What is Novo Nordisk A/S quarterly total expenses year-on-year change?
Over the past year, NVO quarterly total expenses has changed by +$726.36M (+10.48%)